Patents Assigned to Translational Drug Development
  • Heterocyclic compounds as kinase inhibitors
    Patent number: 10633393
    Abstract: The present invention is directed to certain amides and heterocyclic compounds. The present invention also relates to uses of these compounds to treat several diseases including autoimmune disorders, cardiovascular disorders, inflammation, central nervous system disorders, arterial thrombotic disorders, fibrotic disorders, glaucoma, and neoplastic disorders.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: April 28, 2020
    Assignee: Translational Drug Development
    Inventors: Tong Wang, Stephen Gately